Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.0400
+0.0010 (2.56%)
Feb 12, 2026, 2:47 PM EST

RMTG Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
5.044.112.411.530.440.06
Revenue Growth (YoY)
56.88%70.44%57.49%249.46%694.97%82.98%
Cost of Revenue
2.031.280.730.650.290.04
Gross Profit
3.012.821.680.880.150.01
Selling, General & Admin
2.972.472.071.729.930.45
Operating Expenses
3.122.692.381.879.970.45
Operating Income
-0.110.13-0.71-0.99-9.82-0.44
Interest Expense
-6.46-5.64-6.49-4.4-2.72-4.2
Other Non Operating Income (Expenses)
-0.07-0.05-0-0.18-0.1-1.25
EBT Excluding Unusual Items
-6.64-5.56-7.2-5.58-12.64-5.89
Impairment of Goodwill
---4.13---
Legal Settlements
-----0.23-
Other Unusual Items
-0.42-1.51---0.01
Pretax Income
-7.06-5.56-9.81-5.58-12.87-5.9
Earnings From Continuing Operations
-7.06-5.56-9.81-5.58-12.87-5.9
Earnings From Discontinued Operations
---0.07-0.01-
Net Income
-7.06-5.56-9.81-5.51-12.88-5.9
Net Income to Common
-7.06-5.56-9.81-5.51-12.88-5.9
Shares Outstanding (Basic)
13131212119
Shares Outstanding (Diluted)
13131212119
Shares Change (YoY)
0.22%0.68%1.86%6.42%22.91%76.09%
EPS (Basic)
-0.56-0.44-0.79-0.45-1.12-0.63
EPS (Diluted)
-0.56-0.44-0.79-0.45-1.12-0.63
Free Cash Flow
-0.750.64-0.8-1.31-9.88-0.32
Free Cash Flow Per Share
-0.060.05-0.07-0.11-0.86-0.04
Gross Margin
59.76%68.73%69.53%57.31%34.29%20.20%
Operating Margin
-2.24%3.25%-29.30%-64.99%-2242.37%-791.53%
Profit Margin
-140.06%-135.44%-407.21%-359.87%-2942.42%-10703.47%
Free Cash Flow Margin
-14.90%15.47%-33.40%-85.78%-2255.99%-585.94%
EBITDA
0.040.35-0.4-0.84-9.78-0.44
EBITDA Margin
0.83%8.62%-16.44%-55.01%--
D&A For EBITDA
0.150.220.310.150.040
EBIT
-0.110.13-0.71-0.99-9.82-0.44
EBIT Margin
-2.24%3.25%-29.30%-64.99%--
Advertising Expenses
-0.460.480.320.130
Source: S&P Global Market Intelligence. Standard template. Financial Sources.